ONCE-WEEKLY TRANSCON® CNP (NAVEPEGRITIDE) TO RECEIVE 10 YEARS OF MARKET EXCLUSIVITY UPON APPROVAL IN THE EUROPEAN UNION

Reuters · 1d ago

Please log in to view news